T3 Pharma

Developer of novel and innovative medicines to treat cancer

placeBasel, Basel Stadt, Switzerland calendar_todayFounded 2015 groups18 employees language t3pharma.com

Social engagement

Social engagement: 4.2K social following, 2 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include Wille Finance, Boehringer Ingelheim Venture Fund; 1 has since exited.

Investor typeCountShare
Venture capital360%
Angel & family office120%
Accelerator & incubator120%

Recent activity

15 Jun 2026
Event
Große Research Conference on Microbial Therapies
Coming soon